Patent details

EP2822590 Title: IL-17 ANTIBODY FORMULATION

Basic Information

Publication number:
EP2822590
PCT Application Number:
PCT/US/2013/028516
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP137102141
PCT Publication Number:
WO/2013/134052
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
IL-17 ANTIBODY FORMULATION
French Title of Invention:
FORMULATION D'ANTICORPS IL-17
German Title of Invention:
IL-17-ANTIKÖRPERFORMULIERUNG
SPC Number:

Dates

Filing date:
01/03/2013
Grant date:
26/10/2016
EP Publication Date:
26/10/2016
PCT Publication Date:
12/09/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/01/2015
EP B1 Publication Date:
26/10/2016
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
01/03/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
01/03/2013
 
 

Name:
Eli Lilly and Company
Address:
Lilly Corporate Center, Indianapolis, IN 46285, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
14/12/2016
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
CORVARI Vincent, John
Address:
United States (US)

2

Name:
WILLIAMS Barbara, Ann
Address:
United States (US)

3

Name:
MARKHAM Aaron, Paul
Address:
United States (US)

4

Name:
DONOVAN Patrick, Daniel
Address:
United States (US)

Priority

Priority Number:
201261607671
Priority Date:
07/03/2012
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 39/395;

Annual Fees

Annual Fee Due Date:
31/03/2027
Annual Fee Number:
15
Annual Fee Amount:
213 Euro
Expected Payer:
Last Annual Fee Payment Date:
19/02/2026
Last Annual Fee Paid Number:
14
Last Annual Fee Paid Amount:
198 Euro
Payer:
ANAQUA SERVICES (ANC. SGA2)
Filing date Document type Number of pages